Answers are grounded in this paper and cite their sources.
The overuse of short-acting beta agonists is an indicator of poor asthma control and a risk factor for asthma attacks and death. Poor adherence with prevention treatment is the most common cause of poor control and must be addressed before any changes to treatment are made. There are a range of treatment options available to achieve and maintain asthma control. Understanding the underlying causes of symptoms will enable clinicians to provide safe and effective clinical care for patients with asthma.
No takes yet. Share an insight, caveat, or question.
Viv Marsh (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: